Wei H - Search Results

1

PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.

Jie Y, Liu G, Feng L, Li Y, E M, Wu L, Li Y, Rong G, Li Y, Wei H, Gu A. Jie Y, et al. Among authors: wei h. Front Immunol. 2021 Aug 12;12:665970. doi: 10.3389/fimmu.2021.665970. eCollection 2021. Front Immunol. 2021. PMID: 34475869 Free PMC article.

2

The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy.

Wu L, Xie S, Wang L, Li J, Han L, Qin B, Zhang G, Wu Q, Gao W, Zhang L, Wei H, Liu T, Jiao S. Wu L, et al. Among authors: wei h. Front Immunol. 2021 Apr 12;12:665147. doi: 10.3389/fimmu.2021.665147. eCollection 2021. Front Immunol. 2021. PMID: 33912192 Free PMC article.

3

Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib.

Xie S, Li Y, Li X, Wang L, Yang N, Wang Y, Wei H. Xie S, et al. Among authors: wei h. Oncotarget. 2015 Apr 20;6(11):9206-19. doi: 10.18632/oncotarget.3280. Oncotarget. 2015. PMID: 25826078 Free PMC article.

4

Ascites-derived IL-6 and IL-10 synergistically expand CD14⁺HLA-DR^-/low myeloid-derived suppressor cells in ovarian cancer patients.

Wu L, Deng Z, Peng Y, Han L, Liu J, Wang L, Li B, Zhao J, Jiao S, Wei H. Wu L, et al. Among authors: wei h. Oncotarget. 2017 Aug 10;8(44):76843-76856. doi: 10.18632/oncotarget.20164. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100353 Free PMC article.

5

The prevalence of Th17 cells in patients with gastric cancer.

Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma L, Xue X, Wei G, Liu X, Fang G. Zhang B, et al. Among authors: wei g, wei h. Biochem Biophys Res Commun. 2008 Sep 26;374(3):533-7. doi: 10.1016/j.bbrc.2008.07.060. Epub 2008 Jul 23. Biochem Biophys Res Commun. 2008. PMID: 18655770

6

Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.

Pan F, Mao H, Bu F, Tong X, Li J, Zhang S, Liu X, Wang L, Wu L, Chen R, Wei H, Li B, Li C, Yang Y, Steer CJ, Zhao J, Guo Y. Pan F, et al. Among authors: wei h. Oncotarget. 2017 Jan 24;8(4):5735-5752. doi: 10.18632/oncotarget.13902. Oncotarget. 2017. PMID: 27974696 Free PMC article.

7

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, Zhu J, Wei H, Zhao K. Zhang B, et al. Among authors: wei h. PLoS One. 2013;8(2):e57114. doi: 10.1371/journal.pone.0057114. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437326 Free PMC article.

8

Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.

Wei H, Wang H, Lu B, Li B, Hou S, Qian W, Fan K, Dai J, Zhao J, Guo Y. Wei H, et al. Cancer Res. 2008 May 15;68(10):3854-62. doi: 10.1158/0008-5472.CAN-07-6051. Cancer Res. 2008. PMID: 18483270

9

[Construction of specific artificial antigen-presenting cells for in vitro activation of CD19 chimeric antigen receptor T cells].

Peng YJ, Wu QY, Liu HY, Zhao J, Wei HF. Peng YJ, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2017 May 20;37(5):581-587. doi: 10.3969/j.issn.1673-4254.2017.05.03. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28539278 Free PMC article. Chinese.

10

Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.

Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y. Wei H, et al. Clin Cancer Res. 2009 Jul 15;15(14):4612-21. doi: 10.1158/1078-0432.CCR-08-3321. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,580 results

Search Page

Filters